PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.

Authors : Tuyaerts S, Van Nuffel AMT, Naert E, van Dam PA, Vuylsteke P, De Caluwe A, Aspeslagh S, Dirix P, Lippens L, De Jaeghere E, Amant F, Vandecasteele K, Denys H
Year : 2019
Journal : BMC Cancer
Volume : 19
Pages : 506